Early Peanut Introduction for Allergy Prevention: Evidence and Practical Implementation in Pediatric Practice

Area of Science:

• Allergy and Immunology
• Pediatric Allergy
• Immunological Tolerance

Background:

• Peanut allergy is a prevalent and serious childhood condition with lifelong implications.
• Historically, delayed introduction of allergenic foods was advised to prevent sensitization.
• Emerging evidence challenges this approach, suggesting early exposure may be protective.

Purpose of the Study:

• To review the evidence supporting early oral exposure to peanut protein for allergy prevention.
• To synthesize findings from key trials and epidemiological data.
• To provide practical guidance for implementing early introduction strategies.

Main Methods:

• Narrative review of epidemiological observations and clinical trial data.
• Focus on the Learning Early About Peanut Allergy (LEAP) trial and its long-term follow-up.
• Inclusion of data from the Enquiring About Tolerance trial and pooled analyses.

Main Results:

• Early oral introduction of peanut protein in infancy promotes immune tolerance, not sensitization.
• The LEAP trial demonstrated a significant reduction in peanut allergy risk with early exposure.
• Long-term follow-up confirms the durability of this protective effect into adolescence.

Conclusions:

• The paradigm for peanut allergy prevention has shifted towards early oral exposure.
• Risk-stratified guidance supports the integration of early peanut introduction into pediatric care.
• Current recommendations emphasize safety and practical implementation for tolerance induction.